| 24.88 Real-Time Quote |  -0.27 / -1.07%Today’s Change | 17.56 Today|||52-Week Range 25.43 | +18.19% Year-to-Date |
| THC to Refinance Senior Notes - Analyst Blog May 17 / Zacks.com | Quest Diagnostics Upgraded to Neutral - Analyst Blog May 10 / Zacks.com |
| Previous close | 25.15 |
| Today’s open | 25.01 |
| Day’s range | 24.76 - 25.09 |
| Volume | 284,894 |
| Average volume (3 months) | 721,280 |
| Market cap | $2.2B |
| Dividend yield | -- |
| Earnings growth (last year) | -53.21% |
| Earnings growth (this year) | +11.03% |
| Earnings growth (next 5 years) | +11.50% |
| Revenue growth (last year) | +14.43% |
| P/E ratio | 55.2 |
| Price/Sales | 1.09 |
| Price/Book | 1.88 |
| No competitors data available. |
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | $0.44 |
| Annual revenue (last year) | $1.7B |
| Annual profit (last year) | $45.6M |
| Net profit margin | 2.68% |
Sector Health Services |
Industry Medical/Nursing Services |
Chairman, President & Chief Executive Officer Robert L. Antin, MBA |
Chief Operating Officer & Senior Vice President Arthur J. Antin |
Corporate headquarters Los Angeles, California |
.
